← Eichor
Study identifier: NCT07186426 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Condition: Postoperative Pain Management  ·  Sponsor: Haisco Pharmaceutical Group Co., Ltd.

PhasePhase 3
Planned participants405
Who can joinAll sexes, 18 Years to 74 Years
Healthy volunteersNo

About this study

This is a multi-center, randomized, double-blind, placebo/active-controlled study. 405 subjects undergoing orthopedic surgery under general anesthesia are planned to be enrolled and randomized into the HSK21542 group, morphine group, and placebo group.

This description comes directly from the study's public registry record.

Talk to the study team

Jianwei Tang  ·  028-67258779  ·  tangjianw@haisco.com

Always discuss trial participation with your own doctor first.

Locations (2)

Xuanwu Hospital Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
Xiangya Hospital of Central South UniversityChangsha, Hunan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07186426